Company: CMND
Filing Date: 2025-06-12
Form Type: POS AM
Source: 0001213900-25-053898
Chunk: 4

Company: Clearmind Medicine Inc.
Filing Date: 2025-06-12
Form: POS AM
Chunk 4
---
 page 5.

Neither the Securities and Exchange Commission, or the SEC, nor the Canadian Securities Exchange, nor any state or other foreign securities commission has approved nor disapproved these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is ,
2025.

TABLE OF CONTENTS</div>

| PROSPECTUS SUMMARY                     |     |  1 |
| THE OFFERING                           |     |  4 |
| RISK FACTORS                           |     |  5 |
| SPECIAL NOTE REGARDING FORWARD-LOOKING 
 STATEMENTS                             |     |  6 |
| USE OF PROCEEDS                        |     |  8 |
| DIVIDEND POLICY                        |     |  8 |
| CAPITALIZATION                         |     |  9 |
| SELLING SHAREHOLDERS                   |     | 10 |
| DESCRIPTION OF SHARE CAPITAL           |     | 13 |
| DESCRIPTION OF WARRANTS                |     | 23 |
| PLAN OF DISTRIBUTION                   |     | 24 |
| EXPENSES OF THIS OFFERING              |     | 25 |
| LEGAL MATTERS                          |     | 25 |
| EXPERTS                                |     | 26 |
| ENFORCEMENT OF CIVIL LIABILITIES       |     | 26 |
| WHERE YOU CAN FIND MORE INFORMATION    |     | 26 |
| INCORPORATION OF CERTAIN INFORMATION   
 BY REFERENCE                           |     | 27 |

You should rely only on the information contained in this prospectus and any free writing prospectus prepared by or on behalf of us or to which we have referred you. Neither we nor the selling shareholders authorized anyone to provide you with information that is different. We are offering to sell our securities, and seeking offers to buy our securities, only in jurisdictions where offers and sales are permitted. The information in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of our securities.

For investors outside
of the United States: Neither we nor the selling shareholders have done anything that would permit this offering or possession or distribution
of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You are required to
inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus.

<div align='center'>i</